Amyloid-β (Aβ) and apolipoprotein E (APOE) E4 status are incorporated into AD spectrum classification criteria, playing key roles in early diagnosis (Schmechel, 1995; Castellano et al., 2011). Here, APOE is linked to Alzheimer disease.